2-226995471-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001167608.3(RHBDD1):c.897C>T(p.Leu299=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00153 in 1,613,318 control chromosomes in the GnomAD database, including 32 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0082 ( 16 hom., cov: 32)
Exomes 𝑓: 0.00083 ( 16 hom. )
Consequence
RHBDD1
NM_001167608.3 synonymous
NM_001167608.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.106
Genes affected
RHBDD1 (HGNC:23081): (rhomboid domain containing 1) Enables serine-type endopeptidase activity. Involved in several processes, including cellular response to unfolded protein; membrane protein proteolysis; and positive regulation of protein catabolic process. Located in endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 2-226995471-C-T is Benign according to our data. Variant chr2-226995471-C-T is described in ClinVar as [Benign]. Clinvar id is 769592.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.106 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00822 (1251/152270) while in subpopulation AFR AF= 0.0282 (1172/41560). AF 95% confidence interval is 0.0269. There are 16 homozygotes in gnomad4. There are 562 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 16 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RHBDD1 | NM_001167608.3 | c.897C>T | p.Leu299= | synonymous_variant | 9/9 | ENST00000392062.7 | NP_001161080.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RHBDD1 | ENST00000392062.7 | c.897C>T | p.Leu299= | synonymous_variant | 9/9 | 5 | NM_001167608.3 | ENSP00000375914 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00821 AC: 1249AN: 152152Hom.: 16 Cov.: 32
GnomAD3 genomes
AF:
AC:
1249
AN:
152152
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00216 AC: 540AN: 250390Hom.: 6 AF XY: 0.00159 AC XY: 215AN XY: 135228
GnomAD3 exomes
AF:
AC:
540
AN:
250390
Hom.:
AF XY:
AC XY:
215
AN XY:
135228
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000832 AC: 1215AN: 1461048Hom.: 16 Cov.: 29 AF XY: 0.000698 AC XY: 507AN XY: 726724
GnomAD4 exome
AF:
AC:
1215
AN:
1461048
Hom.:
Cov.:
29
AF XY:
AC XY:
507
AN XY:
726724
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00822 AC: 1251AN: 152270Hom.: 16 Cov.: 32 AF XY: 0.00755 AC XY: 562AN XY: 74458
GnomAD4 genome
AF:
AC:
1251
AN:
152270
Hom.:
Cov.:
32
AF XY:
AC XY:
562
AN XY:
74458
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 19, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at